Jiangsu Hengrui Medicine Co Ltd (600276) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.09x

Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥446.90 Million (capex CN¥446.90 Million ) from operating cash flow of CN¥4.81 Billion. Explore Jiangsu Hengrui Medicine Co Ltd (600276) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.09x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥446.90 Million
Capex + Investments

Operating Cash Flow

CN¥4.81 Billion
CNY

Capital Expenditures

CN¥446.90 Million
CNY

Jiangsu Hengrui Medicine Co Ltd Cash Flow Reinvestment Rate (1999–2024)

Historical reinvestment intensity for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Also explore 600276 total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Jiangsu Hengrui Medicine Co Ltd (1999–2024)

Year-by-year capital reinvestment analysis for Jiangsu Hengrui Medicine Co Ltd. For live market cap and broader valuation context, see Jiangsu Hengrui Medicine Co Ltd stock valuation.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 0.27x CN¥2.00 Billion CN¥7.42 Billion CN¥1.97 Billion ▼ -50.5%
2023 0.55x CN¥4.17 Billion CN¥7.64 Billion CN¥1.48 Billion ▼ -71.0%
2022 1.88x CN¥2.38 Billion CN¥1.27 Billion CN¥1.99 Billion ▲ +216.9%
2021 0.59x CN¥2.51 Billion CN¥4.22 Billion CN¥1.66 Billion ▼ -20.4%
2020 0.75x CN¥2.56 Billion CN¥3.43 Billion CN¥554.33 Million ▲ +26.4%
2019 0.59x CN¥2.25 Billion CN¥3.82 Billion CN¥561.35 Million ▼ -47.3%
2018 1.12x CN¥3.11 Billion CN¥2.77 Billion CN¥529.11 Million ▼ -16.7%
2017 1.35x CN¥3.43 Billion CN¥2.55 Billion CN¥380.30 Million ▲ +31.4%
2016 1.02x CN¥2.65 Billion CN¥2.59 Billion CN¥1.11 Billion ▲ +395.4%
2015 0.21x CN¥470.55 Million CN¥2.28 Billion CN¥394.09 Million ▲ +9.0%
2014 0.19x CN¥298.52 Million CN¥1.57 Billion CN¥298.52 Million ▼ -42.9%
2013 0.33x CN¥453.30 Million CN¥1.36 Billion CN¥453.30 Million ▼ -31.8%
2012 0.49x CN¥466.83 Million CN¥958.37 Million CN¥466.83 Million ▼ -52.5%
2011 1.02x CN¥540.27 Million CN¥527.36 Million CN¥540.27 Million ▲ +37.9%
2010 0.74x CN¥286.73 Million CN¥385.95 Million CN¥286.73 Million ▲ +130.3%
2009 0.32x CN¥141.65 Million CN¥439.12 Million CN¥141.65 Million ▼ -65.9%
2008 0.95x CN¥111.21 Million CN¥117.46 Million CN¥111.21 Million ▲ +210.0%
2007 0.31x CN¥66.85 Million CN¥218.87 Million CN¥66.85 Million ▼ -5.8%
2006 0.32x CN¥86.29 Million CN¥266.18 Million CN¥86.29 Million ▲ +17.1%
2005 0.28x CN¥63.07 Million CN¥227.88 Million CN¥63.07 Million ▼ -26.7%
2004 0.38x CN¥79.11 Million CN¥209.41 Million CN¥79.11 Million ▼ -76.1%
2003 1.58x CN¥216.62 Million CN¥136.82 Million CN¥216.62 Million ▼ -35.8%
2002 2.47x CN¥122.90 Million CN¥49.84 Million CN¥122.90 Million ▼ -89.7%
2001 23.99x CN¥275.58 Million CN¥11.49 Million CN¥275.58 Million ▲ +478.2%
2000 4.15x CN¥81.34 Million CN¥19.61 Million CN¥81.34 Million ▲ +591.8%
1999 0.60x CN¥20.32 Million CN¥33.89 Million CN¥20.32 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow